GB0713363D0 - Diagnosis and treatment of abnormal blood conditions - Google Patents

Diagnosis and treatment of abnormal blood conditions

Info

Publication number
GB0713363D0
GB0713363D0 GBGB0713363.0A GB0713363A GB0713363D0 GB 0713363 D0 GB0713363 D0 GB 0713363D0 GB 0713363 A GB0713363 A GB 0713363A GB 0713363 D0 GB0713363 D0 GB 0713363D0
Authority
GB
United Kingdom
Prior art keywords
abnormal blood
treatment
platelet activation
diagnosis
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0713363.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EUROP CARDIOVASCULAR GENETICS
Original Assignee
EUROP CARDIOVASCULAR GENETICS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EUROP CARDIOVASCULAR GENETICS filed Critical EUROP CARDIOVASCULAR GENETICS
Priority to GBGB0713363.0A priority Critical patent/GB0713363D0/en
Publication of GB0713363D0 publication Critical patent/GB0713363D0/en
Priority to PCT/GB2008/002364 priority patent/WO2009007724A2/en
Ceased legal-status Critical Current

Links

Abstract

Methods for diagnosing whether a subject has, or is at risk of, an abnormal blood condition are described. The methods comprise determining the expression level of a gene specifically associated with adenosine-di-phosphate (ADP)-stimulated platelet activation, collagen-related peptide (CRP)-stimulated platelet activation, or ADP- and CRP-stimulated platelet activation in a biological sample obtained from the subject. Methods for identifying potential therapeutic agents for the treatment of abnormal blood conditions are also described.
GBGB0713363.0A 2007-07-10 2007-07-10 Diagnosis and treatment of abnormal blood conditions Ceased GB0713363D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0713363.0A GB0713363D0 (en) 2007-07-10 2007-07-10 Diagnosis and treatment of abnormal blood conditions
PCT/GB2008/002364 WO2009007724A2 (en) 2007-07-10 2008-07-10 Diagnosis and treatment of abnormal blood conditions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0713363.0A GB0713363D0 (en) 2007-07-10 2007-07-10 Diagnosis and treatment of abnormal blood conditions

Publications (1)

Publication Number Publication Date
GB0713363D0 true GB0713363D0 (en) 2007-08-22

Family

ID=38461326

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0713363.0A Ceased GB0713363D0 (en) 2007-07-10 2007-07-10 Diagnosis and treatment of abnormal blood conditions

Country Status (2)

Country Link
GB (1) GB0713363D0 (en)
WO (1) WO2009007724A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112877418A (en) * 2021-01-11 2021-06-01 丰能医药科技（上海）有限责任公司 Product for detecting vascular permeability and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040067903A1 (en) * 2000-08-02 2004-04-08 Alison Williams-Gagnon Nucleic acids encoding a novel regulator of g protein signaling, rgs18, and uses thereof
EP1224942A1 (en) * 2001-01-23 2002-07-24 Bernhard Dr. Nieswandt Use of JAQ1 (monoclonal antibody anti GPVI) as a medicament for the protection against thrombotic diseases

Also Published As

Publication number Publication date
WO2009007724A3 (en) 2009-03-26
WO2009007724A2 (en) 2009-01-15

Similar Documents

Publication Publication Date Title
ATE456055T1 (en) DIAGNOSTIC METHODS FOR DISEASES RELATED TO BRAIN DAMAGE
BRPI0507442B8 (en) in vitro method of diagnosing a pregnant human subject as having or with a propensity to develop pre-eclampsia or eclampsia
ATE525648T1 (en) TEST ELEMENT WITH NANOFIBERS
WO2006133287A3 (en) Expression profiles of peripheral blood mononuclear cells for inflammatory bowel diseases
MX342791B (en) Elisa for vegf.
WO2006073682A3 (en) Diagnostic test
WO2008122670A3 (en) Human diabetes susceptibility tnfrsf10b gene
EP2503338A3 (en) CD73 as a biomarker for monitoring development of diseases and assessing the efficacy of therapies
NZ578283A (en) Proteomic profiling method useful for condition diagnosis and monitoring, composition screening, and therapeutic monitoring
WO2020055954A3 (en) Methods for detecting liver diseases
MX2009005941A (en) Companion diagnostic assays for cancer therapy.
AR080361A1 (en) IDENTIFICATION, EVALUATION AND THERAPY OF CANCERES WITH INNATE RESISTANCE OR ACQUIRED TO QUINASA INHIBITORS OF ANAPLASIC LYMPHOMA (ALK)
MX2021008797A (en) Treatment of ophthalmic conditions with angiopoietin-like 7 (angptl7) inhibitors.
WO2007015113A3 (en) New protein isoforms of the pif-family and uses thereof
WO2005118403A3 (en) Methods for detecting gene expression in peripheral blood cells and uses thereof
SG161216A1 (en) A method of diagnosis and treatment and agents useful for same
MX2009001070A (en) Use of melanoma inhibitory activity (mia) protein as an early indicator for therapeutic response in melanoma.
WO2009133197A3 (en) Levels of april in serum and use in diagnostic methods
WO2015121737A3 (en) Transcriptomic biomarkers, method for determination thereof and use of trnascriptomic biomarkers for individual risk assessment of developing post-infraction heart failure
GB0713363D0 (en) Diagnosis and treatment of abnormal blood conditions
WO2008112990A3 (en) Methods of diagnosis and treatment of crohn's disease
MX2018011679A (en) Biomarkers of proteopathies and uses thereof.
WO2007015094A3 (en) Use of peptides for imaging blood clots
WO2008122435A3 (en) Use gene variants of the human meis1, btbd9, map2k5, lbxcor1, ptprd or a2bp1 gene for diagnostic and therapeutic approaches to restless legs syndrome (rls)
MA34381B1 (en) METHOD FOR PREDICTING THERAPEUTIC RESPONSE IN PATIENTS WITH MULTIPLE SCLEROSIS

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)